1,510
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Antigenicity, pathogenicity and immunosuppressive effect caused by a South American isolate of infectious bursal disease virus belonging to the “distinct” genetic lineage

, , , , , , , , , , , , & show all
Pages 245-254 | Received 31 Oct 2018, Accepted 17 Jan 2019, Published online: 12 Feb 2019

Figures & data

Figure 1. Phylogenetic inferences deduced from nucleotide sequences corresponding to the partial hvVP2 region (left) and the partial VP1 gene (right). Main genetic lineages are indicated with shaded boxes. The names of the corresponding genogroups are indicated within brackets. Both trees were inferred using the maximum-likelihood method with the GTR + I+G nucleotide substitution model. Approximate likelihood ratio test support values are shown for relevant nodes. South American and European dIBDV strains analysed in this study are indicated with bold letters and black circles.

Figure 1. Phylogenetic inferences deduced from nucleotide sequences corresponding to the partial hvVP2 region (left) and the partial VP1 gene (right). Main genetic lineages are indicated with shaded boxes. The names of the corresponding genogroups are indicated within brackets. Both trees were inferred using the maximum-likelihood method with the GTR + I+G nucleotide substitution model. Approximate likelihood ratio test support values are shown for relevant nodes. South American and European dIBDV strains analysed in this study are indicated with bold letters and black circles.

Table 1. Antigenic characterization of the Uruguayan dIBDV strain by AC-ELISA. Light grey = reduced binding; black grey = lack of binding.

Figure 2. Pathogenicity of the South American dIBDV strain compared to the European very virulent strain 89163. (A) Survival rate of 6-week-old SPF chickens infected intranasally with each strain or mock-inoculated, during a 10-day period post inoculation. (B) Mean symptomatic indexes of chickens recorded within 10 days post infection. (C) Bursa to body weight (BBW) ratios calculated 21 days post infection. Statistically significant differences (P < 0.05) between selected groups are indicated with different lowercase letters.

Figure 2. Pathogenicity of the South American dIBDV strain compared to the European very virulent strain 89163. (A) Survival rate of 6-week-old SPF chickens infected intranasally with each strain or mock-inoculated, during a 10-day period post inoculation. (B) Mean symptomatic indexes of chickens recorded within 10 days post infection. (C) Bursa to body weight (BBW) ratios calculated 21 days post infection. Statistically significant differences (P < 0.05) between selected groups are indicated with different lowercase letters.

Figure 3. Immunosuppressive effect produced by the South American and European dIBDV strains. (A) HI mean titres observed 15 days after administration of the NDV vaccine in the vaccinated control group, European dIBDV strain (80/GA)-infected group and South American dIBDV strain (1/chicken/URY/1302/16)-infected group. Mean HI titres of unvaccinated control group were also measured. The dotted line indicates the positivity threshold. (B) Number of dead and alive chicks 15 days after infection with the NDV virulent strain Herts/33 for each group. Mortality percentages are shown. Statistically significant differences (P < 0.05) between selected groups are indicated with different lowercase letters.

Figure 3. Immunosuppressive effect produced by the South American and European dIBDV strains. (A) HI mean titres observed 15 days after administration of the NDV vaccine in the vaccinated control group, European dIBDV strain (80/GA)-infected group and South American dIBDV strain (1/chicken/URY/1302/16)-infected group. Mean HI titres of unvaccinated control group were also measured. The dotted line indicates the positivity threshold. (B) Number of dead and alive chicks 15 days after infection with the NDV virulent strain Herts/33 for each group. Mortality percentages are shown. Statistically significant differences (P < 0.05) between selected groups are indicated with different lowercase letters.
Supplemental material

Supplemental Material

Download MS Word (218.1 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.